Overview
Parkway Corporate Limited is an Australia-based firm specializing in the healthcare industry. The company primarily operates extensive networks of private hospitals and medical centers across various locations. One of its key projects includes the development and management of advanced medical facilities that offer specialized treatments and services tailored towards improving patient care and outcomes. Additionally, Parkway Corporate has been involved in significant research and development initiatives aimed at pioneering innovative healthcare solutions and technologies. These efforts underscore the company's commitment to enhancing healthcare quality and accessibility, making it a notable player in the global healthcare sector. The company leverages a combination of strategic partnerships and cutting-edge technology to sustain its growth and expand its market reach.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Parkway Corporate Limited as of 31 December 2024 is 14.24 MM.
- The operating income for Parkway Corporate Limited as of 31 December 2024 is -0.10 MM.
- The net income for Parkway Corporate Limited as of 31 December 2024 is -0.55 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2024-12-31 | 14.24 | -0.10 | -0.55 |
| 2024-09-30 | 11.59 | -0.33 | -0.64 |
| 2024-06-30 | 8.95 | -0.55 | -0.73 |
| 2024-03-31 | 6.75 | -0.69 | -0.79 |
| 2023-12-31 | 4.55 | -0.83 | -0.84 |
| 2023-09-30 | 4.40 | -1.09 | -1.26 |
| 2023-06-30 | 4.25 | -1.34 | -1.68 |
| 2023-03-31 | 3.98 | -1.64 | -2.00 |
| 2022-12-31 | 3.72 | -1.93 | -2.31 |
| 2022-09-30 | 3.60 | -2.07 | -2.32 |
| 2022-06-30 | 3.48 | -2.20 | -2.33 |
| 2022-03-31 | 3.07 | -1.88 | -2.48 |
| 2021-12-31 | 2.65 | -1.56 | -2.63 |
| 2021-09-30 | 1.92 | -1.28 | -1.78 |
| 2021-06-30 | 1.18 | -1.01 | -0.92 |
| 2021-03-31 | 0.60 | -1.35 | -0.84 |
| 2020-12-31 | 0.01 | -1.68 | -0.75 |
| 2020-09-30 | 0.02 | -1.78 | -1.59 |
| 2020-06-30 | |||
| 2020-03-31 |
Income Statement: EPS
- The earnings per share basic for Parkway Corporate Limited as of 31 December 2024 is -0.00.
- The earnings per share diluted for Parkway Corporate Limited as of 31 December 2024 is -0.00.
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2024-12-31 | -0.00 | -0.00 |
| 2024-09-30 | -0.00 | -0.00 |
| 2024-06-30 | -0.00 | -0.00 |
| 2024-03-31 | -0.00 | -0.00 |
| 2023-12-31 | -0.00 | -0.00 |
| 2023-09-30 | -0.00 | -0.00 |
| 2023-06-30 | -0.00 | -0.00 |
| 2023-03-31 | -0.00 | -0.00 |
| 2022-12-31 | -0.00 | -0.00 |
| 2022-09-30 | -0.00 | -0.00 |
| 2022-06-30 | -0.00 | -0.00 |
| 2022-03-31 | -0.00 | -0.00 |
| 2021-12-31 | -0.00 | -0.00 |
| 2021-09-30 | -0.00 | -0.00 |
| 2021-06-30 | -0.00 | -0.00 |
| 2021-03-31 | -0.00 | -0.00 |
| 2020-12-31 | -0.00 | -0.00 |
| 2020-09-30 | -0.00 | -0.00 |
| 2020-06-30 | -0.00 | -0.00 |
| 2020-03-31 | -0.00 | -0.00 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Parkway Corporate Limited as of 31 December 2024 is 1.54 MM.
- The cash from investing activities for Parkway Corporate Limited as of 31 December 2024 is -3.40 MM.
- The cash from financing activities for Parkway Corporate Limited as of 31 December 2024 is 0.73 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2024-12-31 | 1.54 | -3.40 | 0.73 |
| 2024-09-30 | 1.09 | -3.59 | 2.68 |
| 2024-06-30 | 0.64 | -3.78 | 4.62 |
| 2024-03-31 | -0.16 | -2.29 | 4.00 |
| 2023-12-31 | -0.97 | -0.80 | 3.38 |
| 2023-09-30 | -1.15 | -0.62 | 1.57 |
| 2023-06-30 | -1.34 | -0.44 | -0.23 |
| 2023-03-31 | -1.78 | -0.38 | -0.11 |
| 2022-12-31 | -2.22 | -0.33 | 0.00 |
| 2022-09-30 | -2.17 | -0.84 | 0.01 |
| 2022-06-30 | -2.12 | -1.34 | 0.01 |
| 2022-03-31 | -2.42 | -0.64 | 2.45 |
| 2021-12-31 | -2.71 | 0.06 | 4.88 |
| 2021-09-30 | -2.58 | 0.69 | 5.73 |
| 2021-06-30 | -2.45 | 1.33 | 6.57 |
| 2021-03-31 | -2.20 | 0.65 | 4.14 |
| 2020-12-31 | -1.95 | -0.02 | 1.71 |
| 2020-09-30 | -1.72 | 0.12 | 2.41 |
| 2020-06-30 | |||
| 2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Parkway Corporate Limited as of 31 December 2024 is -45.21.
- The p/book for Parkway Corporate Limited as of 31 December 2024 is 2.14.
- The p/tbv for Parkway Corporate Limited as of 31 December 2024 is 4.99.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2024-12-31 | -45.21 | 2.14 | 4.99 |
| 2024-09-30 | -30.14 | 1.43 | 3.33 |
| 2024-06-30 | -11.97 | ||
| 2024-03-31 | -11.97 | ||
| 2023-12-31 | -13.46 | 2.77 | 6.38 |
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | -6.70 | 1.65 | 2.99 |
| 2021-12-31 | 67.40 | 1.95 | 3.02 |
| 2021-09-30 | |||
| 2021-06-30 | 56.88 | 1.65 | 2.55 |
| 2021-03-31 | -94.21 | 1.63 | 2.52 |
| 2020-12-31 | -22.52 | 2.12 | 3.64 |
| 2020-09-30 | -9.77 | 1.94 | 3.32 |
| 2020-06-30 | -6.44 | 2.54 | 5.44 |
| 2020-03-31 | -6.43 | 2.48 | 5.33 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Parkway Corporate Limited as of 31 December 2024 is -0.02.
- The ebit (3y)/ev for Parkway Corporate Limited as of 31 December 2024 is -0.04.
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2024-12-31 | -0.02 | -0.04 |
| 2024-09-30 | -0.04 | -0.07 |
| 2024-06-30 | -0.08 | -0.03 |
| 2024-03-31 | -0.08 | -0.03 |
| 2023-12-31 | -0.08 | -0.09 |
| 2023-09-30 | -0.06 | -0.02 |
| 2023-06-30 | -0.12 | -0.07 |
| 2023-03-31 | -0.10 | -0.08 |
| 2022-12-31 | -0.13 | -0.10 |
| 2022-09-30 | -0.17 | -0.10 |
| 2022-06-30 | -0.15 | -0.09 |
| 2022-03-31 | -0.21 | -0.14 |
| 2021-12-31 | 0.02 | -0.06 |
| 2021-09-30 | 0.00 | -0.05 |
| 2021-06-30 | 0.03 | -0.11 |
| 2021-03-31 | -0.02 | -0.18 |
| 2020-12-31 | -0.05 | -0.20 |
| 2020-09-30 | -0.12 | -0.24 |
| 2020-06-30 | -0.18 | -0.25 |
| 2020-03-31 | -0.18 | -0.24 |
Management Effectiveness
- The roa for Parkway Corporate Limited as of 31 December 2024 is -0.05.
- The roe for Parkway Corporate Limited as of 31 December 2024 is -0.05.
- The roic for Parkway Corporate Limited as of 31 December 2024 is -0.03.
- The croic for Parkway Corporate Limited as of 31 December 2024 is 0.06.
- The ocroic for Parkway Corporate Limited as of 31 December 2024 is 0.03.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2024-12-31 | -0.05 | -0.05 | -0.03 | 0.06 | 0.03 |
| 2024-09-30 | -0.05 | -0.06 | -0.03 | 0.06 | 0.03 |
| 2024-06-30 | -0.07 | ||||
| 2024-03-31 | -0.07 | ||||
| 2023-12-31 | -0.14 | -0.15 | -0.11 | -0.02 | -0.11 |
| 2023-09-30 | -0.15 | -0.18 | -0.12 | ||
| 2023-06-30 | -0.18 | -0.17 | -0.15 | -0.18 | -0.12 |
| 2023-03-31 | -0.18 | -0.21 | -0.18 | -0.21 | -0.16 |
| 2022-12-31 | -0.18 | -0.22 | -0.21 | -0.27 | -0.19 |
| 2022-09-30 | -0.22 | -0.21 | -0.27 | -0.19 | |
| 2022-06-30 | -0.20 | -0.20 | -0.21 | -0.32 | -0.19 |
| 2022-03-31 | -0.20 | -0.21 | -0.23 | -0.06 | -0.22 |
| 2021-12-31 | 0.04 | 0.04 | -0.22 | 0.18 | -0.23 |
| 2021-09-30 | -0.22 | -0.22 | -0.15 | ||
| 2021-06-30 | 0.05 | 0.06 | 0.03 | 0.44 | -0.23 |
| 2021-03-31 | -0.03 | -0.03 | -0.02 | 0.21 | -0.20 |
| 2020-12-31 | -0.10 | -0.10 | -0.09 | -0.03 | -0.24 |
| 2020-09-30 | -0.21 | -0.22 | -0.20 | 0.10 | -0.22 |
| 2020-06-30 | -0.82 | -0.91 | -0.39 | 0.31 | -0.24 |
| 2020-03-31 | -0.80 | -0.89 | -0.39 | 0.35 | -0.20 |
Gross Margins
- The gross margin for Parkway Corporate Limited as of 31 December 2024 is 0.28.
- The net margin for Parkway Corporate Limited as of 31 December 2024 is -0.08.
- The operating margin for Parkway Corporate Limited as of 31 December 2024 is -0.06.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2024-12-31 | 0.28 | -0.08 | -0.06 |
| 2024-09-30 | 0.28 | -0.08 | -0.06 |
| 2024-06-30 | 0.61 | -0.40 | -0.31 |
| 2024-03-31 | 0.61 | -0.40 | -0.31 |
| 2023-12-31 | 0.61 | -0.40 | -0.31 |
| 2023-09-30 | 0.65 | -0.40 | -0.31 |
| 2023-06-30 | 0.60 | -0.40 | -0.31 |
| 2023-03-31 | 0.60 | -0.50 | -0.42 |
| 2022-12-31 | 0.57 | -0.64 | -0.54 |
| 2022-09-30 | 0.57 | -0.64 | -0.54 |
| 2022-06-30 | 0.60 | -0.67 | -0.59 |
| 2022-03-31 | 0.60 | -0.81 | -0.59 |
| 2021-12-31 | 0.64 | -1.46 | -1.34 |
| 2021-09-30 | -1.66 | -2.00 | |
| 2021-06-30 | 0.64 | 1.41 | -6.65 |
| 2021-03-31 | 0.66 | -1.60 | -12.86 |
| 2020-12-31 | 1.00 | -58.27 | -130.10 |
| 2020-09-30 | 1.00 | -74.90 | -84.04 |
| 2020-06-30 | 1.00 | -82.22 | -63.80 |
| 2020-03-31 | 1.00 | -55.58 | -37.91 |
Identifiers and Descriptors
| Central Index Key (CIK) |
